Background: We evaluated the value of CHADS2 and CHA2DS2-VASc scores in predicting immediate and late stroke after coronary artery bypass grafting (CABG).
Methods: One thousand two hundred twenty-six patients without preoperative atrial fibrillation underwent CABG and form the basis of this community-wide study. The main outcome endpoint of this study was any ischemic stroke with occurred immediately of late after CABG.
Results: During a mean follow-up of 7.2±4.5 years, 114 patients (9.3%) suffered a stroke. Freedom from stroke at 30 days and at 1-, 5-, and 10-year follow-ups were 97.5%, 96.8%, 92.0%, and 87.7%, respectively. After excluding immediate postoperative strokes, the stroke rate per 100 patients per year was 1.36. Postoperative atrial fibrillation (relative risk [RR] 1.483; 95% confidence interval [CI] 1.009-2.179), age (RR 1.039; 95% CI 1.015-1.063), history of stroke (RR 2.951; 95% CI 1.797-4.846), vascular disease (RR 1.732; 95% CI 1.111-2.700), and previous CABG (RR 3.185; 95% CI 1.268-7.997) were independent predictors of any stroke. CHADS2 (c-statistic 0.646) and CHA2DS2-VASc (c-statistic 0.668) predicted 30-day postoperative stroke (for increasing CHADS2 risk classes: 1.6%, 1.6%, and 4.8%, respectively [P=.008]; for increasing CHA2DS2-VASc risk classes: 0.9%, 0.7%, and 3.3 % [P=.043]). Both risk scores predicted late stroke. At 10 years of follow-up, freedom from stroke in high-risk CHADS2 was 80.4% and for high-risk CHA2DS2-VASc was 85.1%. These risk scoring methods predicted also any fatal stroke (c-statistics: CHADS2 0.641 [P=.040]; CHA2DS2-VASc 0.716 [P=.002]).
Conclusions: A significant number of patients may suffer stroke late after CABG, and patients with a high risk of stroke can be identified by CHADS2 and CHA2DS2-VASc scores independently from the presence of pre- or postoperative atrial fibrillation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2012.11.004 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Net Benefit of Early Anticoagulation for Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial.
JAMA Netw Open
January 2025
Department of Neurology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland.
Importance: The net clinical effect of early vs later direct oral anticoagulant (DOAC) initiation after atrial fibrillation-associated ischemic stroke is unclear.
Objective: To investigate whether early DOAC treatment is associated with a net clinical benefit (NCB).
Design, Setting, And Participants: This was a post hoc analysis of the Early Versus Late Initiation of Direct Oral Anticoagulants in Post-Ischaemic Stroke Patients With Atrial Fibrillation (ELAN) open-label randomized clinical trial conducted across 103 sites in 15 countries in Europe, the Middle East, and Asia between November 6, 2017, and September 12, 2022, with a 90-day follow-up.
Nelonemdaz and Patients With Acute Ischemic Stroke and Mechanical Reperfusion: The RODIN Randomized Clinical Trial.
JAMA Netw Open
January 2025
Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Importance: Nelonemdaz selectively antagonizes the 2B subunit of the N-methyl-d-aspartate glutamate receptor and scavenges free radical species.
Objective: To evaluate whether nelonemdaz enhances the clinical outcomes of patients with acute ischemic stroke undergoing emergent reperfusion therapy.
Design, Setting, And Participants: This multicenter double-blind placebo-controlled randomized phase 3 trial (December 25, 2021, to June 30, 2023, in South Korea) recruited patients with acute ischemic stroke who met the following criteria: National Institutes of Health Stroke Scale score greater than or equal to 8, Alberta Stroke Program Early Computed Tomography score greater than or equal to 4, and endovascular thrombectomy within 12 hours after stroke onset.
Left atrial appendage velocity, association with inflammatory indices in non-valvular atrial fibrillation patients.
Future Cardiol
January 2025
Echocardiography research Center, Rajaie cardiovascular medical and research Center, Iran University of Medical Science, Tehran, Iran.
Introduction: Decreased left atrial appendage emptying velocity (LAAV) is a marker for thrombus formation. This study evaluates the association between LAAV and inflammatory indices in non-valvular atrial fibrillation (AF) patients.
Methods: The study population was 1428 patients with AF, 875 of whom enrolled.
Pharmacoinformatics-based screening and construction of a neutralizing anti-SARS-CoV-2 camelidae nanobody drug conjugate.
Mol Divers
January 2025
Department of Biochemistry, University of Delhi South Campus, Benito Juarez Road, Dhaula Kuan, New Delhi, 110021, India.
Nanobodies or variable antigen-binding domains (VH) derived from heavy chain-only antibodies (HcAb) occurring in the Camelidae family offer certain superior physicochemical characteristics like enhanced stability, solubility, and low immunogenicity compared to conventional antibodies. Their efficient antigen-binding capabilities make them a preferred choice for next-generation small biologics. In the present work, we design an anti-SARS-CoV-2 bi-paratopic nanobody drug conjugate by screening a nanobody database.
View Article and Find Full Text PDFAssessment of Reperfusion Efficacy of Altelyse Versus Actilyse in Patients with Acute Myocardial Infarction: A Phase 3, Randomized, Double-Blinded, Non-inferiority Clinical Trial.
Clin Drug Investig
January 2025
Department of Cardiology, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Background: Primary percutaneous coronary intervention (PPCI) and fibrinolytic or thrombolytic therapy are common treatments for ST-elevation myocardial infarction (STEMI). Primary percutaneous coronary intervention is more effective than thrombolytic therapy, but fibrinolytic therapy is still a preferable option for patients with limited access to healthcare. Alteplase is a tissue plasminogen activator (tPA) used to treat acute myocardial infarction, acute ischemic stroke, and pulmonary embolism.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!